8AP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Agios Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 28.8 EUR 5.88% Market Closed

Market Cap: €1.6B

A	Agios Pharmaceuticals Inc F:8AP	US
M	Macy's Inc DUS:FDO	US
F	Fresenius SE & Co KGaA F:FREA	DE
	NetEase Inc F:4Y01	CN
	Orange SA F:FTE	FR
	Midland Exploration Inc XTSX:MD	CA
M	Mastercard Inc XMUN:M4I	US
	KDDI Corp F:DIP0	JP
	Smart Eye AB (publ) F:SE9	SE

Profitability Summary

Agios Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

90% > 90%

Negative Operating Margin

-720%

Negative 3Y Average Operating Margin

-777%

Operating Margin is Increasing

-1 990% > -720%

Negative Net Margin

-640%

Negative 3Y Average Net Margin

-54%

Net Margin is Increasing

-1 146% > -640%

Negative Free Cash Flow Margin

-582%

Negative 3Y Average Free Cash Flow Margin

-1 016%

Free Cash Flow Margin is Increasing

-1 627% > -582%

Negative ROE

-33%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-94% > -88%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.